<DOC>
	<DOCNO>NCT01282060</DOCNO>
	<brief_summary>The purpose study asses link glycaemic balance ( summarised HBA1C LEVEL ) specific cause death .</brief_summary>
	<brief_title>Association Between Glycaemic Control Morbi/Mortality After 5 Years Follow-up Type 2 Diabetic Patients</brief_title>
	<detailed_description>The GERODIAB study first prospective , longitudinal follow-up cohort study , main aim ass link glycaemic balance ( evaluated basis HbA1c level ) total mortality 5 year diabetic patient age 70 , suffer type 2 diabetes . An extension 10 year consider give innovative feature cohort follow-up procedure . The secondary endpoint follow : - To assess link glycaemic balance mortality rate specific cause . - To assess link glycaemic balance onset change diabetes-related complication : cardiovascular disease , change renal function , diabetic retinopathy , peripheral neuropathy , perforate ulcer foot acute metabolic complication . - To assess link glycaemic balance nutritional status , onset change cognitive disorder loss autonomy . - To specify role cardiovascular risk factor combine glycaemic balance , mortality , diabetes-related complication , cognitive disorder loss autonomy .</detailed_description>
	<criteria>Patient type 2 diabetes , age 70 , Patient receive medicinal nonmedicinal treatment ( case diabetic treat insulin , length time diagnosis diabetes onset insulin therapy least 2 year ) , Diabetes diagnose least one year , Patient autonomy define score great equal 3/6 ADL scale , Patient monitor hospital private consultation next 10 year , Patient refuse take part study receive information study ( Patient Information Leaflet ) , Patients monitor hospital private sector throughout France . Patient type 1 diabetes , Patient secondary diabetes ( mainly corticosteroidinduced ) , Patient loss autonomy define score less 3/6 ADL scale , Patient monitor month year come , Patient acute situation ( transient exclusion criterion ) , Patient express refusal participate study .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HBA1C</keyword>
	<keyword>DIABETES-RELATED COMPLICATIONS</keyword>
	<keyword>GLYCAEMIC BALANCE</keyword>
</DOC>